GALECTIN THERAPEUTICS INC — Director's Dealing 2012

Jul 20, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2012-07-18

Reporting Person: Greenberg Arthur (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-18	Common Stock	P	5000	$1.84	Acquired	94667	Direct

Footnotes

F1: The reporting person in a Form 4 filed on April 18, 2012, voluntarily reported a purchase of the issuer's common stock on April 17, 2012, that was a small acquisition within the meaning of Rule 16a-6 under the Exchange Act that qualified for deferred reporting on Form 5. Had the reporting person elected deferred reporting under Rule 16a-6 for the April 17, 2012 purchase, such purchase when aggregated with the purschase reported herein would have triggered a Form 4 report pursuant to Rule 16a-6(a)(1), but insofar as it has been previously reported, the prior purchase, to avoid confusion, is not included in this report.